CD40 ligation mediates plaque-associated tau phosphorylation in β-amyloid overproducing mice

被引:8
作者
Laporte, Vincent [1 ]
Ait-Ghezala, Ghania [1 ]
Volmar, Claude-Henry [1 ]
Ganey, Christopher [1 ]
Ganey, Nowell [1 ]
Wood, Marcie [1 ]
Mullan, Michael [1 ]
机构
[1] Roskamp Inst, Sarasota, FL 34243 USA
关键词
Alzheimer's disease; amyloid; CD40; ligand; mice; transgenic; Tg2576; microtubule-associated protein tau; hyperphosphorylated tau; cdk5; dystrophic neurite;
D O I
10.1016/j.brainres.2008.06.032
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neuritic dystrophy with amyloid burden and neurofibrillary tangles are pathological hallmarks of Alzheimer's disease. Genetic disruption of CD40 or CD40L alleviates amyloid burden, astrocytosis, and microgliosis in transgenic animal models of Alzheimer's disease. It has been reported that phosphorylated tau-positive dystrophic neurites are observed in transgenic mice over-expressing human mutant beta-amyloid precursor protein (Tg2576). Here, we studied the pattern of phosphorylated tau (labeled with AT8, CP13, PG5, and PHF1 antibodies) and plaques using immunohistochemical techniques. Phosphorylated tau-positive dystrophic neurites were exclusively associated with Congo red-positive plaques as previously reported. Further, we show that CD40L or CD40 deficiency reduces the mean ratio of dystrophic neurite area to congophilic plaque area and the level of expression of cdk5 and p35/p25 in mice. In addition, we show that in a human neuroblastoma cell line treated with CD40L, cdk5 and p35/p25 are increased. Together, our data suggest that CD40-CD40L interaction has an effect on tau phosphorylation independent of beta-amyloid pathology, and that this effect may occur through a decrease of cdk5 and p35/p25. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:132 / 142
页数:11
相关论文
共 32 条
[1]   Cytokine regulation of CD40 expression in fetal human astrocyte cultures [J].
Abdel-Haq, N ;
Hao, HN ;
Lyman, WD .
JOURNAL OF NEUROIMMUNOLOGY, 1999, 101 (01) :7-14
[2]   Genomic regulation after CD40 stimulation in microglia: Relevance to Alzheimer's disease [J].
Ait-Ghezala, G ;
Mathura, VS ;
Laporte, V ;
Quadros, A ;
Paris, D ;
Patel, N ;
Volmar, CH ;
Kolippakkam, D ;
Crawford, F ;
Mullan, M .
MOLECULAR BRAIN RESEARCH, 2005, 140 (1-2) :73-85
[3]   CD40 promotion of amyloid beta production occurs via the NF-κB pathway [J].
Ait-Ghezala, Ghania ;
Volmar, Claude-Henry ;
Frieling, Jeremy ;
Paris, Daniel ;
Tweed, Miles ;
Bakshi, Pancham ;
Mullan, Michael .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2007, 25 (06) :1685-1695
[4]   CD40, an extracellular receptor for binding and uptake of Hsp70-peptide complexes [J].
Becker, T ;
Hartl, FU ;
Wieland, F .
JOURNAL OF CELL BIOLOGY, 2002, 158 (07) :1277-1285
[5]   Induction of inflammatory mediators and microglial activation in mice transgenic for mutant human P301S tau protein [J].
Bellucci, A ;
Westwood, AJ ;
Ingram, E ;
Casamenti, F ;
Goedert, M ;
Spillantini, MG .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 165 (05) :1643-1652
[6]   Identification of CD40 ligand in Alzheimer's disease and in animal models of Alzheimer's disease and brain injury [J].
Calingasan, NY ;
Erdely, HA ;
Altar, CA .
NEUROBIOLOGY OF AGING, 2002, 23 (01) :31-39
[7]  
Craxton A, 1998, J IMMUNOL, V161, P3225
[8]   α-internexin immunoreactivity reflects variable neuronal vulnerability in Alzheimer's disease and supports the role of the β-amyloid plaques in inducing neuronal injury [J].
Dickson, TC ;
Chuckowree, JA ;
Chuah, MI ;
West, AK ;
Vickers, JC .
NEUROBIOLOGY OF DISEASE, 2005, 18 (02) :286-295
[9]   Involvement of cell cycle progression in survival signaling through CD40 in the B-lymphocyte line WEHI-231 [J].
Hirai, H ;
Adachi, T ;
Tsubata, T .
CELL DEATH AND DIFFERENTIATION, 2004, 11 (03) :261-269
[10]   Transgenic mice expressing Alzheimer amyloid precursor proteins [J].
Hsiao, K .
EXPERIMENTAL GERONTOLOGY, 1998, 33 (7-8) :883-889